levothyroxine sodium
Commercial- Indications
- myxedema coma, primary hypothyroidism, central hypothyroidism (CeH), congenital hypothyroidism, Pituitary TSH suppression
Company intelligence / Profile preview
Jerome Stevens Pharmaceuticals is a commercial-stage, family-owned company specializing in manufacturing FDA-approved small molecule drugs. Its lead branded product, Unithroid (levothyroxine sodium), was the first FDA-approved levothyroxine sodium product for hypothyroidism. The company recently acquired Thyquidity (levothyroxine sodium oral solution) and continues commercial supply of Digoxin for cardiac conditions[1][2][5][7][8].
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jerome Stevens Pharmaceuticals.